 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
AS-5301 |
 |
(PROPYLTHIO)ACETIC ACID |
98%
|
|
Delete |
AS-8561 |
 |
(R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid |
98%
|
|
Delete |
AS-0330 |
 |
(S)-4-Fluorophenylglycine |
98%
|
|
Delete |
JR6-L6036 |
 |
[1,1'-Biphenyl]-4,4'-diol, 3-[2-amino-6-[[(1S)-2-hydroxy-1-phenylethyl]amino]-4-pyrimidinyl]- |
96%
|
$980/10mg, $5980/100mg, 500mg, 1g, 5g |
Delete |
AS-8382 |
 |
1,2,4-Trifluorobenzene |
98%
|
|
Delete |
JR6-L2146 |
 |
1,3-Benzodioxole-5-propanoic acid, ß-amino-, (ßS) |
96%
|
$780/1g, $2480/5g, $6980/25g |
Delete |
AS-0426 |
 |
1-(4-Fluorophenyl)piperazine |
98%
|
|
Delete |
AS-9116 |
 |
1-BROMO-3,5-DIIODOBENZENE |
98%
|
|
Delete |
AS-6116 |
 |
2-AMINO-3-BROMO-5-FLUOROBENZOIC ACID |
98%
|
|
Delete |
AS-2272 |
 |
2-BROMO-5-CHLOROANISOLE |
98%
|
|
Delete |
AS-2281 |
 |
2-Bromopyridine-5-carbaldehyde |
98%
|
|
Delete |
AS-0613 |
 |
2-Chloro-3-methoxyaniline |
98%
|
|
Delete |
AS-4439 |
 |
2-Chloro-4-methoxybenzoic acid |
98%
|
|
Delete |
AS-1953 |
 |
2-Fluoro-3-hydroxypyridine |
98%
|
|
Delete |
JR6-L5644 |
 |
3-Butyn-1-ol, 1-acetate |
96%
|
|
Delete |
AS-3870 |
 |
3-Butyn-2-ol |
98%
|
|
Delete |
AS-8660 |
 |
3-FURYLMETHYLAMINE |
98%
|
|
Delete |
AS-5090 |
 |
ALPHA-[BUTYLAMINO]METHYL-P-HYDROXYBENZYL ALCOHOL |
98%
|
|
Delete |
JR6-L4077 |
 |
Benzenebutanoic acid, ß-amino-4-(trifluoromethyl)-, (ßS)- |
96%
|
$680/1g, $2980/5g |
Delete |
JR6-L3546 |
 |
Benzeneethanol, a-(chloromethyl)-4-methoxy-3-methyl-, (aR)- |
96%
|
|
Delete |
AS-5767 |
 |
Entacapone |
98%
|
|
Delete |
JR8-N0167 |
 |
Eriocitrin |
98%
|
$128/20mg, $448/100mg, $1680/500mg, 1g, 5g |
Delete |
JR8-N0993 |
 |
Ethyl 4-methoxycinnamate |
98%
|
|
Delete |
AS-1295 |
 |
N-ME-AIB-OH HCL |
98%
|
|
Delete |
JR6-L5532 |
 |
Oxazolo[5,4-b]pyridine, 2-chloro- |
96%
|
|
Delete |
JR6-L4258 |
 |
Phenol, 4,4'-[[1-(3,5-dichlorophenyl)-1H-pyrazole-3,5-diyl]di-(1E)-2,1-ethenediyl]bis[2-methoxy- |
96%
|
|
Delete |
JR8-N0758 |
 |
Toddalolactone |
98%
|
|
Delete |
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |